期刊
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
卷 56, 期 6, 页码 869-879出版社
WALTER DE GRUYTER GMBH
DOI: 10.1515/cclm-2017-0958
关键词
biomarker; brain cancer; cerebrospinal fluid (CSF); diagnosis; microRNA; prognosis
资金
- Czech Ministry of Health [15-34553A, 15-33158A]
- project MZ CR - RVO (MOU) [00209805]
- Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC [LQ1601]
Cerebrospinal fluid (CSF) is a body fluid that has many important functions and is in direct contact with the extracellular environment of the central nervous system (CNS). CSF serves as both the communication channel allowing the distribution of various substances among the CNS cells and the storage facility for the waste products these cells release. For these reasons, CSF is a potential source of diagnostic biomarkers of many CNS diseases, including brain tumors. Recent studies have revealed that CSF also contains circulating microRNAs (miRNAs), short non-coding RNAs that have been described as biomarkers in many cancers. However, CSF miRNAs are difficult to detect, which is why researchers face major challenges, including technological difficulties in its detection and its lack of standardization. Therefore, this review aims (i) to highlight the potential of CSF miRNAs as diagnostic, prognostic and predictive biomarkers in brain tumors, and (ii) to summarize technological approaches for detection of CSF miRNAs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据